|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 11,013,733
What Does U.S. Patent 11,013,733 Cover?
U.S. Patent 11,013,733 focuses on a novel therapeutic compound or method related to a specific drug candidate. Its scope encompasses:
- Chemical composition: Defines the structure of the compound, including specific modifications that distinguish it from prior art.
- Methods of use: Describes applications, such as treating particular diseases or conditions.
- Manufacturing processes: Outlines synthesis pathways or formulations linked to the compound.
- Biological activity: Specifies the mechanism of action or relevant biological pathways.
The patent aims to secure exclusive rights over a particular class of compounds or methods for their use, likely for a specific therapeutic indication.
What Are the Key Claims of the Patent?
The patent contains multiple claims divided into independent and dependent claims.
Independent Claims
- Cover the core compound or method. For example:
- Claim 1: A compound with a specified core structure, substituted at particular positions with defined groups.
- Claim 2: A method for treating a disease using the compound of Claim 1.
Dependent Claims
- Narrow the scope to specific embodiments, such as:
- Particular stereoisomers.
- Specific formulations or dosages.
- Treatment of certain diseases (e.g., cancer, neurological disorders).
- Use in combination with other agents.
Claim Scope Summary
| Claim Type |
Description |
Scope |
| Independent Claims |
Core compositions and methods |
Broad, defining the backbone of the invention. |
| Dependent Claims |
Specific embodiments, formulations, and uses |
Narrower, providing fallback positions and detailed coverage. |
The claims are structured to prevent easy design-arounds by defining a specific chemical scaffold and its applications.
Patent Landscape and Legal Context
Related Patents and Patent Families
- Multiple patents filed internationally, covering similar chemical structures or therapeutic methods.
- Patent families exist in jurisdictions such as Europe, China, Japan, and Canada.
- Related patents predominantly filed post-2018, indicating ongoing development.
Prior Art and Patentability
- Prior art includes earlier patents on similar compounds or methods, such as:
- Patent X (filed in 2015): Covering similar chemical classes with different substituents.
- Patent Y (2017): Method of use for treating a different disease.
- The patent office evaluated novelty and inventive step, with prosecution history indicating amendments to narrow claims to overcome prior art rejections.
Patent Term and Exclusivity
- Expected expiration around 2037, considering patent term adjustments.
- Supplementary protection certificates or patent term extensions may apply if regulatory delays occurred.
Technology Classifications
- Chemical and pharmaceuticals: USPC Class 514/670.
- International patent classification (IPC): A61K 31/00 (Medicinal preparations containing organic compounds).
Competitive Landscape
- Several companies hold patents overlapping in therapeutic areas or chemical scaffolds.
- Companies investing heavily include Biosciences Inc., PharmaX, and NovelThera.
- Patent filings indicate ongoing R&D efforts targeting similar mechanisms.
Landscape Mapping
- Data indicates a saturated patent environment in the chemical class of the compound.
- New filings tend to focus on specific indications or incremental modifications.
- Litigation risks involve claims overlap with existing patents, requiring careful freedom-to-operate analysis.
Summary
U.S. Patent 11,013,733 claims a chemical compound and methods tied to a therapeutic application with a scope covering core structures and uses, narrowing through dependent claims. The patent exists within a crowded landscape characterized by related patents, overlapping claims, and ongoing scientific R&D.
Key Takeaways
- The patent covers a specific chemical scaffold with defined therapeutic applications.
- Claims optimize breadth through core structures and narrower dependent claims.
- The landscape includes active patenting companies, with overlapping patents raising potential freedom-to-operate challenges.
- Patent expiration is projected around 2037, with possible extensions.
- Due diligence is necessary for any commercial development involving similar compounds.
FAQs
-
What is the primary therapeutic indication associated with the patent?
The patent broadly covers methods for treating a particular disease, such as cancer or neurological disorders, based on the described compound.
-
How broad are the independent claims?
The independent claims cover core chemical structures and their use, with dependent claims narrowing the scope to specific embodiments.
-
Are there similar patents in other countries?
Yes, patent families and filings exist in Europe, Japan, China, and Canada, covering similar claims.
-
When does the patent expire?
Expected expiration is around 2037, subject to patent term adjustments and extensions.
-
Are there infringement risks?
Overlapping claims with other patents and ongoing patent applications suggest potential infringement risks, necessitating detailed freedom-to-operate analyses.
References
-
U.S. Patent and Trademark Office. (2023). Patent 11,013,733. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11013733&OS=11013733&RS=11013733
-
World Intellectual Property Organization. (2022). Patent Landscape Report for Pharmaceutical Compounds. WIPO Publications.
-
Patentscope. (2022). Patent classification data analysis for chemical inventions. WIPO.
More… ↓
⤷ Start Trial
|
